[ad_1] (RxWiki News) As the season changes and the temperature rises, the risk for heat-related health issues grows. This risk is particularly high for the elderly and those with certain
Fireworks Safety 101 | RxWiki
[ad_1] (RxWiki News) As you prepare to celebrate the Fourth of July, you need to know a few things about fireworks and how to keep your family safe. Fireworks can
3 Tips for a Healthy Pregnancy
[ad_1] (RxWiki News) Whether you are trying to have a baby or just thinking about it, informing yourself is a good first step. Here are three tips to get you
Summer Safety for Kids | RxWiki
[ad_1] (RxWiki News) The sun is shining, the swimmers are splashing and the kids are hitting the playgrounds. Don’t let injuries and illnesses ruin the summer fun. A) Heat-Related Illnesses
Companies Selling Kratom Products Under Fire
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has issued warnings to two companies for illegally selling kratom products. These companies, Cali Botanicals of Folsom, California, and Kratom
Botox Approved for Children | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a medication to ease upper limb spasticity in children. This medication is known by the brand name Botox,
Diabetes Medication Now Approved for Children
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a diabetes medication for use in children. This injection is found under the brand name Victoza (active ingredient
New Rx for Women Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a medication for low sexual desire in women. This new medication is called Vyleesi (bremelanotide). The FDA approved
Swimming This Summer? | RxWiki
[ad_1] (RxWiki News) Don’t let injuries and illnesses ruin the fun of swimming this summer. This week is Healthy and Safe Swimming Week. This week and this summer, practice the
Another Biosimilar to Herceptin | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer. This biosimilar is called Kanjinti (trastuzumab-anns).